Immunotherapy Oral Abstracts
Thursday, May 30, 2024 08:00 AM - 09:00 AM
Room 202-204
Abstract Presentations
- FOXO1 overexpression enhances CAR T cell stemness, metabolic fitness and efficacy, Paul Beavis, Australia
- IL-27 In A Fourth Generation CAR Enhances CAR-NK Cell Effector Function, Alison Felipe Biggi, Brazil
- Development of INGENUI-T, a Rapid Autologous Chimeric Antigen Receptor (CAR)-T Manufacturing Solution Using Whole Blood, For Treatment of Autominnune Disease, Sunetra Biswas, United States
- Real world product quality data of CAR-engineered NK cells for intracranial injection in patients with recurrent HER2-positive glioblastoma from the ongoing CAR2BRAIN clinical trial, Elisabeth Ehrend, Germany
- Anti-Cancer Characteristics of Personalized Neoantigen-Based T-Cell Therapy For Solid Tumours, Shuen-Iu Hung, Taiwan
- Developing a First-In-Class Universal Allogenic SNAP-CAR NK Cell Therapy, Braxton Jamison, United States
